Arvinas, Inc.
ARVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001655759
No open-market purchases or sales by Arvinas, Inc. insiders were filed in the last 90 days; 201 institutions reported holding it in 13F filings for Q2 2026, worth $468.7M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Arvinas, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 211
- −3 vs. Q2 2025
- Shares held
- 67.0M
- −2.68M (−3.8%) vs. Q2 2025
- Total value
- $570.7M
- +$57.7M (+11.2%) vs. Q2 2025
- New holders
- 35
- 68 more added
- Sold out
- 38
- 72 more reduced
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 201 | $468.7M |
| Q1 2026 | 207 | $572.6M |
| Q4 2025 | 206 | $662.9M |
| Q3 2025 | 211 | $570.7M |
| Q2 2025 | 215 | $513.8M |
| Q1 2025 | 216 | $456.7M |
| Q4 2024 | 199 | $1.47B |
| Q3 2024 | 206 | $1.78B |
| Q2 2024 | 207 | $1.89B |
| Q1 2024 | 223 | $2.84B |
| Q4 2023 | 213 | $2.67B |
| Q3 2023 | 155 | $959.0M |
| Q2 2023 | 156 | $1.16B |
| Q1 2023 | 171 | $1.34B |
| Q4 2022 | 162 | $1.71B |
| Q3 2022 | 174 | $2.22B |
| Q2 2022 | 172 | $2.08B |
| Q1 2022 | 179 | $3.16B |
| Q4 2021 | 199 | $3.69B |
| Q3 2021 | 205 | $3.64B |
| Q2 2021 | 181 | $3.52B |
| Q1 2021 | 181 | $2.88B |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Arvinas, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| TCG Crossover Management, LLC | 1,617,365 | $13.8M | 0.68% | +1,617,365 | New |
| Morgan Stanley | 1,662,221 | $14.2M | 0.00% | +78,492+5.0% | Added |
| Geode Capital Management, LLC | 1,670,179 | $14.2M | 0.00% | +85,087+5.4% | Added |
| State Street Corp | 1,873,086 | $16.0M | 0.00% | +140,763+8.1% | Added |
| Millennium Management LLC | 2,131,555 | $18.2M | 0.01% | +233,483+12.3% | Added |
| D. E. Shaw & Co., Inc. | 3,347,163 | $28.5M | 0.02% | +1,196,433+55.6% | Added |
| Pfizer Inc | 3,457,815 | $29.5M | 6.73% | 00.0% | Unchanged |
| Logos Global Management LP | 5,575,000 | $47.5M | 4.69% | +2,275,000+68.9% | Added |
| BlackRock, Inc. | 6,802,938 | $58.0M | 0.00% | −86,514−1.3% | Reduced |
| Vanguard Group Inc | 8,561,232 | $72.9M | 0.00% | −831,929−8.9% | Reduced |
| DekaBank Deutsche Girozentrale | 42,000 | – | – | 00.0% | Unchanged |
| Caption Management, LLC | 0 | $0 | 0.00% | −1,343,029−100.0% | Sold out |
| Madison Avenue Partners, LP | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| Velan Capital Investment Management LP | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| 22NW, LP | 0 | $0 | 0.00% | −413,533−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −275,663−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −104,318−100.0% | Sold out |
| Gilder Gagnon Howe & Co LLC | 0 | $0 | 0.00% | −99,271−100.0% | Sold out |
| Diadema Partners LP | 0 | $0 | 0.00% | −96,455−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −93,433−100.0% | Sold out |
| Nebula Research & Development LLC | 0 | $0 | 0.00% | −76,747−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −74,152−100.0% | Sold out |
| NEOS Investment Management LLC | 0 | $0 | 0.00% | −72,114−100.0% | Sold out |
| Tema ETFs LLC | 0 | $0 | 0.00% | −72,114−100.0% | Sold out |
| Palumbo Wealth Management LLC | 0 | $0 | 0.00% | −66,858−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −57,157−100.0% | Sold out |
| Clear Harbor Asset Management, LLC | 0 | $0 | 0.00% | −56,080−100.0% | Sold out |
| Polymer Capital Management (US) LLC | 0 | $0 | 0.00% | −54,617−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| IMC-Chicago, LLC | 0 | $0 | 0.00% | −40,403−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −36,244−100.0% | Sold out |
| Winton Group Ltd | 0 | $0 | 0.00% | −32,354−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −31,877−100.0% | Sold out |
| Ieq Capital, LLC | 0 | $0 | 0.00% | −28,908−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −26,269−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −22,878−100.0% | Sold out |
| Persistent Asset Partners Ltd | 0 | $0 | 0.00% | −22,233−100.0% | Sold out |
| Cantor Fitzgerald, L. P. | 0 | $0 | 0.00% | −20,117−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −19,808−100.0% | Sold out |
| Mariner, LLC | 0 | $0 | 0.00% | −14,344−100.0% | Sold out |
| 111 Capital | 0 | $0 | 0.00% | −12,926−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −12,689−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −11,045−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −10,728−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −7,100−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −4,590−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −1,218−100.0% | Sold out |
| C M Bidwell & Associates Ltd | 0 | $0 | 0.00% | −520−100.0% | Sold out |
| WealthTrak Capital Management LLC | 0 | $0 | 0.00% | −45−100.0% | Sold out |
| Norges Bank | – | – | – | – | Not filed |